A1C to detect diabetes in healthy adults: when should we recheck? by Takahashi, O, Farmer, A, Shimbo, T, Fukui, T, Glasziou, P

Home measurement of blood pressure and cardiovascular disease: systematic review and meta-analysis of prospective studies. by Ward, A, Takahashi, O, Stevens, R, Heneghan, C

Blood pressure re-screening for healthy adults: What is the best measure and interval by Takahashi, O, Glasziou, P, Perera, R, Shimbo, T, Fukui, T

Blood pressure re-screening for healthy adults: what is the best measure and interval? by Takahashi, O, Glasziou, P, Perera, R, Shimbo, T, Fukui, T

Lipid re-screening: what is the best measure and interval? by Takahashi, O, Glasziou, P, Perera, R, Shimbo, T, Suwa, J, Hiramatsu, S, Fukui, T

THE OPTIMAL INTERVAL OF HBA1C TO DETECT DIABETES IN HEALTHY ADULTS: A LARGE COHORT STUDY IN JAPAN by Takahashi, O, Glasziou, P, Perera, R, Deshpande, G, Ohde, S, Shimbo, T, Fukui, T

Smoking history and emphysema in asthma–COPD overlap by Kurashima K, Takaku Y, Ohta C, Takayanagi N, Yanagisawa T, Kanauchi T, Takahashi O

Get full text

LIPID RE-SCREENING FOR HEALTHY ADULTS; WHAT IS THE BEST INTERVAL AND MEASURE? by Takahashi, O, Perera, R, Stevens, R, Shimbo, T, Suwa, J, Fukui, T, Glasziou, P

Association of code status discussion with invasive procedures among advanced-stage cancer and noncancer patients by Sasaki A, Hiraoka E, Homma Y, Takahashi O, Norisue Y, Kawai K, Fujitani S

Get full text

Submental Muscle Activity and Its Role in Diagnosing Sarcopenic Dysphagia by Sakai K, Nakayama E, Rogus-Pulia N, Takehisa T, Takehisa Y, Urayama KY, Takahashi O

Get full text

Diabetes screening intervals based on risk stratification. by Ohde, S, McFadden, E, Deshpande, G, Yokomichi, H, Takahashi, O, Fukui, T, Perera, R, Yamagata, Z

Early DNR Order and Long-Term Prognosis Among Patients Hospitalized for Acute Heart Failure: Single-Center Cohort Study in Japan by Hiraoka E, Arai J, Kojima S, Norisue Y, Suzuki T, Homma Y, Takahashi O, Obunai K, Watanabe H

Get full text

What is the true definition of a "Do-Not-Resuscitate" order? A Japanese perspective by Hiraoka E, Homma Y, Norisue Y, Naito T, Kataoka Y, Hamada O, Den Y, Takahashi O, Fujitani S

Get full text

Targeted Therapy Against All Three VEGF Receptors by Cediranib Enhances the Antitumor and Anti-metastatic Effects of Paclitaxel and Radiation in an Orthotopic Human Lung Cancer Mod... by Takahashi, O, Komaki, R, Tailor, R, Juergensmeier, J, Ryan, A, Smith, P, Jacoby, J, Korshunova, M, Herbst, R, O'Reilly, MS

MEK1/2 blockade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib by Takahashi, O, Komaki, R, Smith, P, Ryan, A, Jurgensmeier, J, Welsh, J, Jacoby, J, Hosho, K, Korshunova, M, Erez, B, Herbst, R, O'Reilly, MS

Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis. by Takahashi, O, Komaki, R, Smith, P, Jürgensmeier, J, Ryan, A, Bekele, B, Wistuba, I, Jacoby, J, Korshunova, M, Biernacka, A, Erez, B, Hosho, K, Herbst, R, O'Reilly, MS

Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis by Takahashi, O, Komaki, R, Smith, P, Jürgensmeier, J, Ryan, A, Bekele, B, Wistuba, I, Jacoby, J, Korshunova, M, Biernacka, A, Erez, B, Hosho, K, Herbst, R, O'Reilly, MS

Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling by Perera, R, McFadden, E, McLellan, J, Lung, T, Clarke, P, Pérez, T, Fanshawe, T, Dalton, A, Farmer, A, Glasziou, P, Takahashi, O, Stevens, J, Irwig, L, Hirst, J, Stevens, S, Leslie, A, Ohde, S, Deshpande, G, Urayama, K, Shine, B, Stevens, R